Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cinryze for Acute HAE Attacks in Children
NCT01095510Phase 2Completed
- Sponsor
- Takeda
- Start
- Jun 2010
- Primary completion
- Apr 2012
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 3
01
Overview
A Phase 2 trial of c1-esterase inhibitor in hereditary angioedema (HAE), sponsored by Takeda. Started Jun 2010; status: completed.
02
Drugs
c1-esterase inhibitor
03
Conditions
hereditary angioedema (HAE)
Beyond the preview
Go deeper on NCT01095510.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01095510.